Literature DB >> 16297917

Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells.

Andrea Murányi1, Dmitry Derkach, Ferenc Erdodi, Andrea Kiss, Masaaki Ito, David J Hartshorne.   

Abstract

Major sites for Rho-kinase on the myosin phosphatase target subunit (MYPT1) are Thr695 and Thr850. Phosphorylation of Thr695 inhibits phosphatase activity but the role of phosphorylation at Thr850 is not clear and is evaluated here. Phosphorylation of both Thr695 and Thr850 by Rho-kinase inhibited activity of the type 1 phosphatase catalytic subunit. Rates of phosphorylation of the two sites were similar and efficacy of inhibition following phosphorylation was equivalent for each site. Phosphorylation of each site on MYPT1 was detected in A7r5 cells, but Thr850 was preferred by Rho-kinase and Thr695 was phosphorylated by an unidentified kinase(s).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297917     DOI: 10.1016/j.febslet.2005.10.055

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  65 in total

Review 1.  Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions.

Authors:  Kazuo Katoh; Yumiko Kano; Yasuko Noda
Journal:  J R Soc Interface       Date:  2010-09-08       Impact factor: 4.118

2.  Mechanisms underlying potentiation of endothelin-1-induced myofilament Ca(2+) sensitization after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Satoshi Matsuo; Katsuharu Kameda; Mayumi Hirano; Akira Nakamizo; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-28       Impact factor: 6.200

3.  Effect of elevated intracellular cAMP levels on actomyosin contraction in bovine trabecular meshwork cells.

Authors:  Charanya Ramachandran; Rajkumar V Patil; Najam A Sharif; Sangly P Srinivas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-18       Impact factor: 4.799

Review 4.  A role for the Ca(2+)-dependent tyrosine kinase Pyk2 in tonic depolarization-induced vascular smooth muscle contraction.

Authors:  Ryan D Mills; Mitsuo Mita; Michael P Walsh
Journal:  J Muscle Res Cell Motil       Date:  2015-07-07       Impact factor: 2.698

5.  Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels.

Authors:  Paul H Ratz; Amy S Miner
Journal:  J Pharmacol Exp Ther       Date:  2008-11-14       Impact factor: 4.030

6.  Arf guanine nucleotide-exchange factors BIG1 and BIG2 regulate nonmuscle myosin IIA activity by anchoring myosin phosphatase complex.

Authors:  Kang Le; Chun-Chun Li; Guan Ye; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

7.  Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries.

Authors:  Ahmed F El-Yazbi; Rosalyn P Johnson; Emma J Walsh; Kosuke Takeya; Michael P Walsh; William C Cole
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

8.  Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle.

Authors:  Lori D Moffat; Shannon B A Brown; Michael E Grassie; Annegret Ulke-Lemée; Laura M Williamson; Michael P Walsh; Justin A MacDonald
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

9.  Spatiotemporally Controlled Mechanical Cues Drive Progenitor Mesenchymal-to-Epithelial Transition Enabling Proper Heart Formation and Function.

Authors:  Timothy R Jackson; Hye Young Kim; Uma L Balakrishnan; Carsten Stuckenholz; Lance A Davidson
Journal:  Curr Biol       Date:  2017-04-20       Impact factor: 10.834

10.  Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle.

Authors:  Maria Regina Freitas; Masumi Eto; Jason A Kirkbride; Christa Schott; Jean Sassard; Jean-Claude Stoclet
Journal:  Fundam Clin Pharmacol       Date:  2009-03-09       Impact factor: 2.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.